http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021231343-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d133e2f05ba2877fab069fdcde45b05b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-395
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
filingDate 2021-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_236d66b0bc865fb186716736c775b12e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_194a44cc48395642465c50cc8dc80ade
publicationDate 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021231343-A1
titleOfInvention Surfactant protein c mimics displaying pathogen- or allergen-binding moieties
abstract A method is provided for treating a subject. The method comprises diagnosing the subject as suffering from a condition arising from the presence in the subject of a causative agent; and administering to the subject a pharmaceutically effective amount of a substance having (a) a hydrophobic, helical region, (b) an N-terminal region that includes at least one proline residue, (c) a first linking moiety that links the hydrophobic helical region to the N-terminal region, said linking moiety being equipped with at least one lysine-like side chain, (d) a binding moiety which binds to the causative agent, and (e) a second linking moiety that links the binding moiety to the N-terminal region.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021388031-A1
priorityDate 2020-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013109627-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226544943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID984
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398189
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17397414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396466

Total number of triples: 48.